ArticleCancer research communications2024

Exploration of Immune-Modulatory Effects of Amivantamab in Combination with Pembrolizumab in Lung and Head and Neck Squamous Cell Carcinoma.

Sun M Lim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.